{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T21:05:12Z","timestamp":1765487112939},"reference-count":27,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14606","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T12:15:40Z","timestamp":1722600940000},"source":"Crossref","is-referenced-by-count":5,"title":["Evolving approaches in advanced gallbladder cancer with complete pathological response using chemo\u2011immunotherapy: A case report"],"prefix":"10.3892","volume":"28","author":[{"given":"Elena","family":"Orlandi","sequence":"first","affiliation":[{"name":"Department of Oncology\u2011Hematology, Piacenza General Hospital, I\u201129121 Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Toscani","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Hematology, Piacenza General Hospital, I\u201129121 Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Trubini","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Hematology, Piacenza General Hospital, I\u201129121 Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Schena","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Hematology, Piacenza General Hospital, I\u201129121 Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Palladino","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Hematology, Piacenza General Hospital, I\u201129121 Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Anselmi","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Hematology, Piacenza General Hospital, I\u201129121 Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Vecchia","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Piacenza General Hospital, I\u201129121 Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Romboli","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Piacenza General Hospital, I\u201129121 Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Giuffrida","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Piacenza General Hospital, I\u201129121 Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"key20240906090823_b1-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.21141","article-title":"Gallbladder cancer (GBC): 10-Year experience at memorial sloan-kettering cancer centre (MSKCC)","volume":"98","author":"Duffy","year":"2008","journal-title":"J Surg Oncol"},{"key":"key20240906090823_b2-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.surg.2013.04.022","article-title":"Aggressive surgical management of gallbladder cancer: At what cost?","volume":"154","author":"Jin","year":"2013","journal-title":"Surgery"},{"key":"key20240906090823_b3-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"key20240906090823_b4-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.3390\/cancers15133312","article-title":"Immunotherapy in biliary tract cancers: Current standard-of-care and emerging strategies","volume":"15","author":"Lo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20240906090823_b5-ol-28-4-14606","first-page":"678","article-title":"Durvalumab plus gemcitabine and cisplatin for advanced biliary tract cancers: A phase III study (TOPAZ-1)","volume":"12","author":"Oh","year":"2022","journal-title":"Cancer Discov"},{"key":"key20240906090823_b6-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"key20240906090823_b7-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"1124482","DOI":"10.3389\/fimmu.2023.1124482","article-title":"Case report: Persistent response to combination therapy of pemigatinib, chemotherapy, and immune checkpoint inhibitor in a patient with advanced intrahepatic cholangiocarcinoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"key20240906090823_b8-ol-28-4-14606","first-page":"89","article-title":"A novel mixture of dose-fractioned radiation and PD-1 inhibitor produces significant tumor control in a patient with advanced intrahepatic cholangiocarcinoma: A case report","volume":"17","author":"Wang","year":"2023","journal-title":"J Med Case Rep"},{"key":"key20240906090823_b9-ol-28-4-14606","first-page":"337","article-title":"PD-1 blockade and radiotherapy combination for advanced Epstein-Barr virus-associated intrahepatic cholangiocarcinoma","volume":"41","author":"Liao","year":"2023","journal-title":"J Clin Oncol"},{"key":"key20240906090823_b10-ol-28-4-14606","first-page":"1","article-title":"Long survival of immunotherapy plus paclitaxel in advanced intrahepatic cholangiocarcinoma with high PD-L1 expression: A case report","volume":"23","author":"He","year":"2022","journal-title":"Cancer Biol Ther"},{"key":"key20240906090823_b11-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"101951","DOI":"10.1016\/j.eclinm.2023.101951","article-title":"Surgical outcomes of gallbladder cancer: The OMEGA retrospective, multicentre, international cohort study","volume":"59","author":"Balakrishnan","year":"2023","journal-title":"EClinicalMedicine"},{"key":"key20240906090823_b12-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"key20240906090823_b13-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/sj.bjc.6604628","article-title":"Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: A phase II study","volume":"99","author":"Andr\u00e9","year":"2008","journal-title":"Br J Cancer"},{"key":"key20240906090823_b14-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejso.2018.08.020","article-title":"The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer-A systematic review","volume":"45","author":"Hakeem","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"key20240906090823_b15-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.3390\/jcm12072654","article-title":"Neoadjuvant therapy for extrahepatic biliary tract cancer: A propensity score-matched survival analysis","volume":"12","author":"Toyoda","year":"2023","journal-title":"J Clin Med"},{"key":"key20240906090823_b16-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40792-022-01375-z","article-title":"Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: A case report","volume":"8","author":"Miura","year":"2022","journal-title":"Surg Case Rep"},{"key":"key20240906090823_b17-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"rjab414","DOI":"10.1093\/jscr\/rjab414","article-title":"A case from the future of HPB surgical oncology: Resection of biliary tract cancer after immunotherapy","volume":"2021","author":"Satyananda","year":"2021","journal-title":"J Surg Case Rep"},{"key":"key20240906090823_b18-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"e255403","DOI":"10.1136\/bcr-2023-255403","article-title":"PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer","volume":"16","author":"Zhang","year":"2023","journal-title":"BMJ Case Rep"},{"key":"key20240906090823_b19-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"1173520","DOI":"10.3389\/fimmu.2023.1173520","article-title":"Case report: Complete pathological remission of human chorionic gonadotrophin-producing gallbladder carcinoma with multiple liver metastases after treatment with chemotherapy plus an immune checkpoint inhibitor","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"key20240906090823_b20-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"1353430","DOI":"10.3389\/fimmu.2024.1353430","article-title":"Case report: From palliative to potentially curative-the advent of immunotherapy providing hope to advanced gallbladder adenocarcinoma","volume":"15","author":"Leong","year":"2024","journal-title":"Front Immunol"},{"key":"key20240906090823_b21-ol-28-4-14606","article-title":"SWOG 1609 cohort 48: Anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer","author":"Patel","year":"2024","journal-title":"Cancer"},{"key":"key20240906090823_b22-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"1006075","DOI":"10.3389\/fonc.2022.1006075","article-title":"PD-1 inhibitors plus nab-paclitaxel-containing chemotherapy for advanced gallbladder cancer in a second-line setting: A retrospective analysis of a case series","volume":"12","author":"Tan","year":"2022","journal-title":"Front Oncol"},{"key":"key20240906090823_b23-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.21037\/atm-20-4420","article-title":"Complete response to immunotherapy combined with an antiangiogenic agent in multiple hepatic metastases after radical surgery for advanced gallbladder cancer: A case report","volume":"8","author":"Rao","year":"2020","journal-title":"Ann Transl Med"},{"key":"key20240906090823_b24-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10555-016-9645-x","article-title":"HER2\/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: A potential therapeutic target?","volume":"36","author":"Galdy","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"key20240906090823_b25-ol-28-4-14606","first-page":"6353","article-title":"Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy","volume":"34","author":"Koido","year":"2014","journal-title":"Anticancer Res"},{"key":"key20240906090823_b26-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s40425-019-0768-9","article-title":"The role of PD-L1 expression as a predictive biomarker: An analysis of all US food and drug administration (FDA) approvals of immune checkpoint inhibitors","volume":"7","author":"Davis","year":"2019","journal-title":"J Immunother Cancer"},{"key":"key20240906090823_b27-ol-28-4-14606","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1634\/theoncologist.2014-0234","article-title":"Oncogenic alterations in ERBB2\/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin","volume":"20","author":"Chmielecki","year":"2015","journal-title":"Oncologist"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T06:08:34Z","timestamp":1725602914000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8,2]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14606","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"article-number":"473"}}